Drug Firms' Proprietary Data Supercharge AI Protein Models, Outperforming Public-Data Systems

Summary

An AI system trained on over 20,000 protein structures from pharmaceutical companies has demonstrated superior performance compared to AlphaFold-like models that rely solely on public data. This advancement, published in Nature, suggests that proprietary data can significantly enhance AI protein modeling.